Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 20,590

Document Document Title
WO/2019/053090A1
The present disclosure provides a compound of formula (I): (I); or a pharmaceutically acceptable salt thereof, and its therapeutic uses for activating a growth factor pathway, promoting wound healing, promoting tissue repair, and treatin...  
WO/2019/052236A1
The present invention pertains to the field of fine chemicals and related chemical technologies and provides a preparation method for a butadiene derivative. Phenylacetylene and derivatives thereof are used as raw materials and react in ...  
WO/2019/054148A1
A fluorine-containing ether compound which is represented by R1-R2-CH2-R3-CH2-R4-R5. (In the formula, R3 represents a perfluoropolyether chain; each of R1 and R5 independently represents an optionally substituted alkyl group, an organic ...  
WO/2019/052980A1
The present invention relates to a compound of formula (I) as defined in the description and in the claims. The compound of formula (I) can be used in the manufacture of medicaments.  
WO/2019/046931A1
Compounds of general formula IA, IB and IC outlined below, including pharmaceutically acceptable salts, solvates and hydrates thereof. Such compounds and pharmaceutical compositions comprising them may be used in medical conditions invol...  
WO/2019/048458A1
The present application relates to compounds of formulas (I) and (II), to methods for the production thereof, and to the use thereof in electronic devices.  
WO/2019/048443A1
The present application relates to compounds of formula (I), to methods for the producing thereof, and to the use thereof in electronic devices.  
WO/2018/139767A9
The present invention provides a novel amine-based compound and an organic light emitting device using the same.  
WO/2019/043060A1
The present invention relates to binaphthyl compounds of the formula (I), which are suitable as monomers for preparing polycarbonate resins having beneficial optical properties and which can be used for producing optical lenses: Formula ...  
WO/2019/043642A1
The present invention relates to novel thiophene compounds of general Formula I, and their stereoisomers (diastereoisomers, enantiomers), pure or mixed, racemic mixtures, geometrical isomers, tautomers, pharmaceutically acceptable salts,...  
WO/2019/039290A1
Provided are: an actinic ray-sensitive or radiation-sensitive resin composition that has excellent resolution, exposure latitude, and pattern shape properties; and a resist film, a pattern-forming method, a method for producing an electr...  
WO/2019/039200A1
Provided is a fluorinated ether compound, which can be used advantageously as a lubricant material for a magnetic recording medium, the lubricant material being capable of forming a lubricant layer having excellent chemical resistance an...  
WO/2019/039265A1
A fluorine-containing ether compound characterized by being represented by formula (1). R1–R2–CH2–R3–CH2–R4–R5 (1) (In formula (1), R3 indicates a perfluoropolyether chain. R2 and R4 indicate a divalent linking group having a...  
WO/2019/035453A1
Provided is a catalyst represented by general formula (1). In general formula (1), R1-R14 each independently represent a hydrogen atom or a substituent.  
WO/2019/036678A1
Described herein, inter alia, are compositions and methods for modulating mu opioid receptor activity.  
WO/2019/033799A1
Disclosed is a compound, with the structure formula thereof being as shown in formula (I) below. The compound disclosed by the present invention can be used as a liquid crystal compound, and at the same time, same also overcomes the prob...  
WO/2019/036624A1
In various embodiments, provided herein are pamoate salts of monoamine Anti-Parkinsons disease agents including rotigotine, ropinirole, pramipexole, selegiline, rasagiline, and safinamide, pharmaceutical composition comprising the same, ...  
WO/2019/036374A1
Described herein are compounds, or pharmaceutically acceptable salts thereof, of the following formula (I). The compounds are useful for treating inflammatory and autoimmune diseases.  
WO/2019/031833A1
Disclosed are a compound represented by chemical formula 1, an organic electronic element comprising a first electrode, a second electrode, and an organic layer between the first electrode and the second electrode, and an electronic devi...  
WO/2019/031605A1
Provided is a fused ring compound which exhibits excellent charge transport ability. A fused ring compound which is represented by formula (1) and has a specific structure.  
WO/2019/030538A1
The invention relates to derivatives of formula (I) where R1, R2, R3, R4, R5, X and m are as defined in the specification. These compounds which have therapeutic activity, in particular, as STAT3 inhibitors and so are useful in the treat...  
WO/2019/025540A1
The invention relates to 3-acyl-benzamides of formula (I) as herbicides. In formula (I) X, Y, Z and Rx represent radicals such as alkyl, cycloalkyl and halogen.  
WO/2019/020654A1
The present application relates to a spirobifluorene derivative of a specific formula (I) which is suitable for use in electronic devices.  
WO/2019/023147A1
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured.The variables shown in Formula AA are as defined in the claims. The compounds of formula AA are NLRP3 activity modulators and, as such, c...  
WO/2019/023145A1
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured. The variables shown in Formula AA are as defined in the claims. The compounds of formula AA are NLRP3 activity modulators and, as such, ...  
WO/2019/020726A1
The invention discloses a method for preparation of alkylated, fluoro alkylated, chloro alkylated and fluorochloro alkylated compounds by a heterogeneous Co-catalysed alkylation or fluoro, chloro and fluorochloro alkylation with alkyl ha...  
WO/2019/018359A1
The present disclosure provides compounds, methods, and compositions which may be used to treat tuberculosis. In some embodiments, these compounds and compositions have a bactericidal property against Mycobacterium tuberculosis (Mtb). Me...  
WO/2019/011826A1
The present invention relates to a ring closure reaction useful in synthesizing fused aromatic or heteroaromatic ring systems, which may, for example, be used as organic semiconductor materials.  
WO/2019/013487A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2019/013503A1
The present invention relates to a novel organic compound and an organic electroluminescent element including the same and, more specifically, to: a novel dibenzofuran-based compound having excellent thermal stability, carrier transport ...  
WO/2019/008152A1
The present invention provides novel compounds of formula (I) that are useful as inhibitors of the PD-l/PD-Ll protein/protein interaction. The compounds may be used in the treatment of cancer, infectious diseases and neurodegenerative di...  
WO/2019/007821A1
The invention relates to 4,6-dihalogen-dibenzothiophene and 4,6-dihalogen-dibenzofuran-3-thioether derivatives of formula (I), in which W, X, R1, R2, A1, Z1 and n are defined as cited in claim 1, to their production, their use as compone...  
WO/2019/002173A1
The present invention relates to a compound of formula (I): wherein the meanings for the various substituents are as disclosed in the description, having dual pharmacological activity towards both the α2δ subunit, in particular the α2...  
WO/2019/004614A1
The present invention provides a novel heterocyclic compound and an organic light emitting element using same.  
WO/2018/235926A1
The purpose of the present invention is to provide an α, β-unsaturated amide compound or a pharmaceutically acceptable salt thereof or the like, which has anti-cancer activity or the like. An α, β-unsaturated amide compound represent...  
WO/2018/231635A1
The present disclosure relates to novel δ-opioid receptor agonists, and the method of making and using the novel δ-opioid receptor agonists. The novel δ-opioid receptor agonists are selective δ-opioid receptor agonists that have subs...  
WO/2018/231015A1
The present specification relates to an anthracene derivative represented by chemical formula 1 and an organic light-emitting device comprising same.  
WO/2018/232298A1
The present invention provides a compound having the structure: and use of the compound for inhibiting the growth of or killing a fungus  
WO/2018/228968A1
The invention relates to compounds of formula (I), in which present groups and parameters have the meanings cited in claim 1, to their preparation, to their use as components in liquid-crystalline media and to electro-optical display ele...  
WO/2018/232358A1
Visibly transparent photovoltaic devices are disclosed, such as those are transparent to visible light but absorb near-infrared light and/or ultraviolet light. The photovoltaic devices make use of transparent electrodes and near-infrared...  
WO/2018/225018A1
The present invention relates to novel heterocyclic compounds of the general formula (I) their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers and polymorphs. The invention also relates...  
WO/2018/217439A1
The present invention relates to novel substituted [5,6]cyclic-4(3H)-pyrimidinone compounds of formula (I) and their preparation methods. (I) In particular, the present invention relates to novel substituted [5,6]cyclic-4(3H)- pyrimidino...  
WO/2018/213150A1
The application relates to phenyl- or naphthylsulfonamide derivatives of the structural formula (I). The compounds are described as inhibitors of USP30 (ubiquitin specific peptidase 30) useful for the treatment of conditions involving mi...  
WO/2018/210631A1
The present invention refers to a process for a Rh-catalyzed Anti-Markovnikov hydrocyanation of terminal alkynes which process discloses, for the first time, the highly stereo- and regio-selective hydrocyanation of terminal alkynes to fu...  
WO/2018/198975A1
Provided is a light-emitting element having excellent luminance life. Disclosed is a light-emitting element comprising a positive electrode, a negative electrode, a first organic layer provided between the positive electrode and the nega...  
WO/2018/198973A1
Provided is a composition that is useful for producing a light-emitting element having excellent external quantum efficiency. Disclosed is a composition comprising at least two types of compounds represented by formula (C-1), and a phosp...  
WO/2018/198971A1
Provided is a composition useful for manufacturing a light-emitting element having excellent light-emitting efficiency. A composition containing a phosphorescent compound represented by formula (1) and a compound represented by formula (...  
WO/2018/199466A1
The present invention provides a novel compound and an organic light-emitting element including same.  
WO/2018/199797A1
The invention relates to the chemistry of organic compounds, pharmacology and medicine, and concerns the prevention and/or treatment of hyperproliferative diseases associated with the malignant transformation of cells expressing the enzy...  
WO/2018/198974A1
Provided is a light-emitting element having excellent luminance life. This light-emitting element comprises: a positive electrode; a negative electrode; and a first organic layer and a second organic layer provided between the positive e...  

Matches 1 - 50 out of 20,590